Ginkgo Bioworks Holdings (DNA) EBITDA Margin (QoQ) (2020 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,603.00 |
| Mar 31, 2026 | -15,465.00 |
| Dec 31, 2025 | 1,992.00 |
| Sep 30, 2025 | -8,316.00 |
| Jun 30, 2025 | 6,318.00 |
| Mar 31, 2025 | 2,449.00 |
| Dec 31, 2024 | -17,429.00 |
| Sep 30, 2024 | 33,466.00 |
| Jun 30, 2024 | 7,246.00 |
| Mar 31, 2024 | -39,584.00 |
| Dec 31, 2023 | 44,340.00 |
| Sep 30, 2023 | -28,811.00 |
| Jun 30, 2023 | 3,877.00 |
| Mar 31, 2023 | -3,244.00 |
| Dec 31, 2022 | 75,149.00 |
| Sep 30, 2022 | -53,846.00 |
| Jun 30, 2022 | -4,688.00 |
| Mar 31, 2022 | 73,351.00 |
| Dec 31, 2021 | -110,018.00 |
| Sep 30, 2021 | 10,301.00 |